Jennifer Humes - 20 Sep 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: Chief Accounting Officer
Issuer ticker: ROIV
Reported as of: 20 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Sep 2026, 21:00:18 UTC
Prior SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Jennifer Humes

Key filing fact

Jennifer Humes filed Form 4 for Roivant Sciences Ltd. (ROIV) on 22 Sep 2026.

Key facts

This page summarizes Jennifer Humes's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Sep 2026, 21:00.

Change

Previous filing in this sequence was filed on 23 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002058012 Primary reporting owner

Humes Jennifer

Relationship: Chief Accounting Officer
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Sam Kaplan, as Attorney-in-Fact for Jennifer Humes
Signature date: 22 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Tax liability

Transaction value
Shares: -3,880
Change %: -3.5%
Price: $39.77^*
Shares after: 106,419
Date: 20 Sep 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Footnote F2

Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.

SEC remarks

Exhibit 24 - Power of Attorney